The 2023 World Life Science Conference Was Successfully HeldThe World Life Science Conference and the Beijing International Life and Health Industry Cross-border Expo opened at the China International Exhibition Center in Beijing on July 11. There are more than 600 exhibitors at home and abroad, and the exhibition displays 50,000 square meters. International health and medical institutions, industry associations, purchasers, agents, industry experts, leaders of embassies in China from the United States, France, Algeria, Myanmar, Nigeria, Greece, Angola and other countries actively participated in the conference, which was a wonderful scene and a warm atmosphere to help domestic and foreign enterprises seek business opportunities and talk about the high-quality development of life and health industry.  Ju Liya, chairman of the Joint organization of the World Life Science Conference, and Liang Wannian, executive Vice president of Tsinghua Vanke School of Public Health and Health, co-chaired the event and introduced that the World Life Science Conference Expo is the world's first international exhibition with the theme of life science, and is a new platform for China to promote the integrated development of the global life science field. It is a practical action and vivid practice to support health globalization and promote the building of a community of human health, and an important measure to promote the construction of a healthy China.Mynard, Director of International Science and Technology cooperation at the French Academy of Sciences, said that Sino-French life sciences and health cooperation channels are becoming broader and broader, and it is expected to produce more new technological achievements in the academic field in the future, and promote cooperation and development in the field of human life sciences。Walter, President of the Federal Pharmaceutical Commission of Brazil, Zidana, President of the Unified Procurement, Medical Supply and Medical Technology Administration of Egypt, Duteit, Deputy Director General of the Department of Science and Technology of South Africa, Victor Urbani, National Secretary of Medical Equality of the Ministry of Health of Argentina, and other overseas guests said in their speeches that they will strengthen cooperation with China's life and health industry in the future. Jointly promote the development of human health.Fan Daiming, Academician of Chinese Academy of Engineering, Tong Xiaolin, academician of Chinese Academy of Sciences, Antoine, Director of International Science and Technology Cooperation of French Academy of Sciences  Zheng Haifa, vice chairman of the company, and other experts visited the exhibition site to share and exchange, to jointly talk about the new power of life science, and to discuss the new future of human life.  The expo attracted industry leaders from Mindray, BTU, Fresenios, Lepu, Yiling Pharmaceutical, Anke, Fosun, Kangtai, and Kangsinuo to participate, and held more than 30 forum activities during the same period, focusing on tumor prevention, biomedicine, pharmaceutical device innovation, intellectual property rights, hospital intelligence and management innovation, big data to help medical treatment and other fields. We will promote the in-depth development of all aspects of life science production, university research and medical treatment. Jointly explore new ideas, new directions and new journeys for the development of human medical and health undertakings.

2024 World Forum of Life Scientists In order to promote the development and innovation of the global life science field, display the latest achievements in the field of life science, discuss the future development trend, strengthen interdisciplinary and cross-border cooperation and exchange, and provide a platform for global life scientists to exchange and cooperate. The World Life Science Conference and World Life Scientists Forum will be held at the China International Exhibition Center (Chaoyang Hall) on September 8, 2024.I. Basic Information of the ForumConference date: September 21, 2024Venue: China International Exhibition Center (Chaoyang Hall)Conference theme: Xiangnew Era of life science, create a better future for mankind.Ii. Introduction to the ForumObjective: The Forum aims to provide an international platform for scholars, entrepreneurs and policy makers in the global life sciences field to promote academic exchange, industry development and policy making.Concept: With "Sharing, cooperation and innovation" as the core concept, the Forum advocates an open, inclusive and diverse academic atmosphere, encourages cross-border cooperation, and promotes innovation and development in the field of life sciences.Features: This forum will focus on the latest life science research results, technologies and applications, involving a wide range of fields, including but not limited to gene editing, immunotherapy, AI application in life sciences, etc., and jointly contribute to promoting the development of life sciences!Iii. Participants1. Representatives of the World Health Organization, relevant United Nations medical organizations, international medical institutions, etc.2. Responsible persons of health commission system, drug supervision system, medical insurance system, emergency system, medical association, medical association, hospital and other institutions.3. Nobel Prize winner, Chinese Academy of Sciences, Harvard University, Oxford University and other medical experts and professors, the world's top life scientists, well-known experts and scholars4. World-renowned life science entrepreneurs, ceos, Ctos, Cfos, etc.Iv. Agenda of the MeetingThe conference will be held at the China International Exhibition Center (Jing Anzhuang) from September 21 to 23, 2024. The specific schedule is as follows:  V. Highlights of the Forum1. Keynote speech: Well-known life scientists at home and abroad will be invited to share the latest achievements and insights in their respective research fields.2. Display of results: Set up an exhibition area to display the latest research results in the field of life science and promote the comprehensive development of industry, university and research.3. Interactive session: Set up a question and answer session, participants and speakers face to face communication.  

World Life Sciences Dinner World Life Scientists Summit Night celebrates great advances in the life sciences and thanks scientists worldwide who have made outstanding contributions to the cause of life sciences. The dinner will showcase the latest research results, discuss cutting-edge scientific issues, build a global cooperation and exchange platform for life sciences, and inject new impetus into the development of life sciences. 1. Basic Information of the dinnerDinner time: 17:30-21:00, September 21, 2024Venue: Beijing Royal Hotel The dinner will include the following sessions:Opening Speech: A representative of the organizer will give an opening speech, thanking all guests for their presence and briefly introducing the purpose and agenda of the dinner.Keynote speech: Two renowned life scientists are invited to give keynote speeches to share the latest research results and cutting-edge views.Panel discussion: The guests will be divided into several groups to have in-depth discussions on various areas of the life sciences and exchange ideas and cooperation intentions.Dinner exchange: In a beautiful atmosphere, guests freely communicate, learn from each other and establish contacts. The dinner will provide a beautiful Chinese and Western buffet, including seafood, barbecue, green salad and other dishes, as well as a variety of drinks and drinks.

Announcement of the State Food and Drug Administration of the State Health Commission of the State Disease Control Bureau on the Issuance of Administrative Regulations on the Emergency Use of Medical Devices (Trial) (No. 150 of 2023) Announcement of the State Medical Products Administration, the National Health Commission, and the National Bureau of Disease Control and Prevention on Issuing the Management Regulations for Emergency Use of Medical Devices (Trial) (No. 150 of 2023)In order to do a good job in emergency response to particularly serious public health emergencies and other serious threats to public health, guide and standardize the emergency use of medical devices, in accordance with the "Regulations on the Supervision and Administration of Medical Devices" (State Council Order No. 739), the National Medical Products Administration, together with the National Health Commission and the National Bureau of Disease Control and Prevention, has organized the formulation of the "Regulations on the Management of Emergency Use of Medical Devices (Trial)", which is now issued, Effective from the date of publication. This announcement is hereby made. National Medical Products Administration, National Health Commission, National Bureau of Disease Control and Prevention　　                            November 23, 2023 

The latest announcement from the National Health Commission is the equipment configuration standards for township health centers and community health service centers! On December 22, the website of the National Health Commission released the "Guidelines for Evaluation of Service Capability of Township Health Centers (2023 Edition)" and "Guidelines for Evaluation of Service Capability of Community Health Service Centers (2023 Edition)". On the basis of the existing service capabilities divided into two levels: "basic standards" and "recommended standards", for township health centers and community health service centers with less than 10 medical personnel and less than 10000 service population, a new "qualified standard" level is added. The evaluation criteria are: in all basic indicator clauses, the proportion of reaching level C is ≥ 80%, the proportion of reaching level B is ≥ 20%, and the proportion of reaching level A is ≥ 5%.   Service capacity of township health centersEvaluation Guide (2023 version) 1. Pediatric medical services The ability to provide primary, secondary and tertiary prevention measures for birth defects, that is, measures taken before and during early pregnancy to prevent birth defects; Screening of newborns after birth, early detection of neonatal diseases and abnormalities, concurrent treatment, consultation and referral services. 2. Health services for the elderly The elderly aged 65 and above were screened and evaluated for five chronic diseases including hypertension, diabetes, coronary heart disease, stroke and COPD through physical examination or special evaluation.   3. Inspection and inspection service [C] Blood routine, urine routine, stool routine, liver function, kidney function, amylase, blood lipids, serum electrolytes, blood glucose detection, ABO erythrocyte typing, ABO blood group identification and other test items. [B-1] Carry out coagulation function, HBA1C, hepatitis B serum markers, HCV antibody, HIV, syphilis antibody detection (preliminary screening), Rh blood group identification, etc. [B-2] Provide 24-hour emergency examination service. Clinical laboratory professional and technical personnel are on duty 24 hours a day to provide 24-hour emergency inspection services. [A-1] Myocardial injury markers, tumor markers, blood gas analysis, microorganisms and other tests were carried out. [A-2] For special testing items that cannot be provided for the temporary needs of clinical diagnosis and treatment, superior hospitals or third-party testing centers can be entrusted to provide services, or multiple hospitals can jointly carry out services, but an entrustment service agreement between hospitals should be signed, and there must be guarantee clauses such as indoor quality control and inter-room quality assessment, as well as time limit for results return. 4. Medical technology and other departments [C] Set up pharmacy, laboratory, radiology department, B-ultrasound room, electrocardiography room (B-ultrasound and electrocardiography room can be combined), disinfection and supply room (can rely on qualified third-party institutions). The above departments meet the requirements of "Township Health Center Construction Standard" (construction standard 107-2008) (if there is a new standard, according to the new standard); Visual reference can be made to "Standard for Visual Design of Functional Units of Primary Medical and Health Institutions" (WS/T 809-2022). 5. Device configuration [B-3] Equipped with DR, color ultrasound, automatic biochemical analyzer, automatic chemiluminescence immunoanalyzer, blood coagulation meter, biosafety cabinet, 12-lead electrocardiogram machine, air disinfection machine, anesthesia machine, ventilator and other equipment matching the diagnosis and treatment subjects.   Service capacity of community health service centerEvaluation Guide (2023 version)   1. Medical technology and other departments [C] Set up pharmacy, laboratory, radiology department, B-ultrasound room, electrocardiography room (B-ultrasound and electrocardiography room can be combined), health information management room, disinfection supply room (can rely on qualified third-party institutions). The number and use area of the above clinical departments shall be determined according to the number of serving population, and shall meet the requirements of the Construction Standard of Community Health Service Center and Station (construction standard 163-2013) (if there is a new standard, it shall be implemented according to the new standard); Visual reference can be made to "Standard for Visual Design of Functional Units of Primary Medical and Health Institutions" (WS/T 809-2022). 2. Device configuration [B-1] Equipped with hearing screening tools, vision screening tools, psychological and behavioral development screening tools. [B-2] Be equipped with other equipment matching the diagnosis and treatment subjects. [B-3] Equipped with air disinfection machine, DR, color ultrasound, automatic biochemical analyzer, blood coagulation meter, 12-lead electrocardiogram machine, ECG monitor, dynamic ECG monitor, dynamic blood pressure monitor, biosafety cabinet. 3. Inspection items [C] Blood routine, urine routine, stool routine, liver function, kidney function, blood lipids, serum electrolytes, blood glucose detection, ABO erythrocyte typing, ABO blood type identification and other test items (can rely on a third party). [B] Blood coagulation function, glycosylated hemoglobin, amylase testing, hepatitis B serum markers, HIV, syphilis antibody testing (preliminary screening), Rh blood group identification, etc. [A-1] Myocardial injury markers, tumor markers, blood gas analysis, microorganisms and other tests were carried out. 【A-2】对中心临床诊疗临时需要而不能提供的特殊检验项目，可委托上级医院或第三方检测中心等单位提供服务，或机构联合开展服务，但应签署机构之间的委托服务协议，必须有室内质控与室间质评，以及结果回报时限等保证条款。评价方式方法：现场查看病历、委托协议，同时查看室内质控与室间质评相关资料。 Source: National Health Commission